Episode Details

Back to Episodes
No More Transfusions!!! Dr. John Scarlett, President and CEO of Geron Corporation

No More Transfusions!!! Dr. John Scarlett, President and CEO of Geron Corporation

Episode 25026 Published 1 year, 4 months ago
Description

Dr. John Scarlett, President and CEO of Geron Corporation talks about their drug Imetelstat for myelodysplastic syndrome (MDS). MDS patients often require frequent blood transfusions, impacting their quality of life. Imetelstat, a telomerase inhibitor, aims to reduce transfusion dependence by targeting cancer cells in the bone marrow. Phase three trials showed promising results, with 40% of patients experiencing at least an 8-week transfusion-free interval. 

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us